Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
<p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://www.jeccr.com/content/31/1/55 |
id |
doaj-209be7221ac54b79bd110873a306f768 |
---|---|
record_format |
Article |
spelling |
doaj-209be7221ac54b79bd110873a306f7682020-11-24T22:20:07ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662012-06-013115510.1186/1756-9966-31-55Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling systemShima KentaroMizuma MasamichiHayashi HirokiNakagawa KeiOkada TakahoSakata NaoakiOmura NoriyukiKitamura YoMotoi FuyuhikoRikiyama ToshikiKatayose YuEgawa ShinichiIshii NaotoHorii AkiraUnno Michiaki<p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred to as NOG-EGFP mice, may be useful for obtaining such high purity cancer cells for detailed molecular and cellular analyses.</p> <p>Methods</p> <p>Pancreato-biliary cancer cell lines were implanted subcutaneously to compare the tumorigenicity between NOG-EGFP mice and nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. To obtain high purity cancer cells, the subcutaneous tumors were harvested from the mice and enzymatically dissociated into single-cell suspensions. Then, the cells were sorted by fluorescence-activated cell sorting (FACS) for separation of the host cells and the cancer cells. Thereafter, the contamination rate of host cells in collected cancer cells was quantified by using FACS analysis. The viability of cancer cells after FACS sorting was evaluated by cell culture and subsequent subcutaneous reimplantation in NOG-EGFP mice.</p> <p>Results</p> <p>The tumorigenicity of NOG-EGFP mice was significantly better than that of NOD/SCID mice in all of the analyzed cell lines (<it>p</it> < 0.01). Sorting procedures enabled an almost pure collection of cancer cells with only slight contamination by host cells. Reimplantation of the sorted cancer cells formed tumors again, which demonstrated that cell viability after sorting was well maintained.</p> <p>Conclusions</p> <p>This method provides a novel cancer sampling system for molecular and cellular analysis with high accuracy and should contribute to the development of personalized medicine.</p> http://www.jeccr.com/content/31/1/55NOG-EGFP mouseXenograftCancerStromal cellSeparation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shima Kentaro Mizuma Masamichi Hayashi Hiroki Nakagawa Kei Okada Takaho Sakata Naoaki Omura Noriyuki Kitamura Yo Motoi Fuyuhiko Rikiyama Toshiki Katayose Yu Egawa Shinichi Ishii Naoto Horii Akira Unno Michiaki |
spellingShingle |
Shima Kentaro Mizuma Masamichi Hayashi Hiroki Nakagawa Kei Okada Takaho Sakata Naoaki Omura Noriyuki Kitamura Yo Motoi Fuyuhiko Rikiyama Toshiki Katayose Yu Egawa Shinichi Ishii Naoto Horii Akira Unno Michiaki Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system Journal of Experimental & Clinical Cancer Research NOG-EGFP mouse Xenograft Cancer Stromal cell Separation |
author_facet |
Shima Kentaro Mizuma Masamichi Hayashi Hiroki Nakagawa Kei Okada Takaho Sakata Naoaki Omura Noriyuki Kitamura Yo Motoi Fuyuhiko Rikiyama Toshiki Katayose Yu Egawa Shinichi Ishii Naoto Horii Akira Unno Michiaki |
author_sort |
Shima Kentaro |
title |
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system |
title_short |
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system |
title_full |
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system |
title_fullStr |
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system |
title_full_unstemmed |
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system |
title_sort |
potential utility of egfp-expressing nog mice (nog-egfp) as a high purity cancer sampling system |
publisher |
BMC |
series |
Journal of Experimental & Clinical Cancer Research |
issn |
1756-9966 |
publishDate |
2012-06-01 |
description |
<p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred to as NOG-EGFP mice, may be useful for obtaining such high purity cancer cells for detailed molecular and cellular analyses.</p> <p>Methods</p> <p>Pancreato-biliary cancer cell lines were implanted subcutaneously to compare the tumorigenicity between NOG-EGFP mice and nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. To obtain high purity cancer cells, the subcutaneous tumors were harvested from the mice and enzymatically dissociated into single-cell suspensions. Then, the cells were sorted by fluorescence-activated cell sorting (FACS) for separation of the host cells and the cancer cells. Thereafter, the contamination rate of host cells in collected cancer cells was quantified by using FACS analysis. The viability of cancer cells after FACS sorting was evaluated by cell culture and subsequent subcutaneous reimplantation in NOG-EGFP mice.</p> <p>Results</p> <p>The tumorigenicity of NOG-EGFP mice was significantly better than that of NOD/SCID mice in all of the analyzed cell lines (<it>p</it> < 0.01). Sorting procedures enabled an almost pure collection of cancer cells with only slight contamination by host cells. Reimplantation of the sorted cancer cells formed tumors again, which demonstrated that cell viability after sorting was well maintained.</p> <p>Conclusions</p> <p>This method provides a novel cancer sampling system for molecular and cellular analysis with high accuracy and should contribute to the development of personalized medicine.</p> |
topic |
NOG-EGFP mouse Xenograft Cancer Stromal cell Separation |
url |
http://www.jeccr.com/content/31/1/55 |
work_keys_str_mv |
AT shimakentaro potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT mizumamasamichi potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT hayashihiroki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT nakagawakei potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT okadatakaho potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT sakatanaoaki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT omuranoriyuki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT kitamurayo potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT motoifuyuhiko potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT rikiyamatoshiki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT katayoseyu potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT egawashinichi potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT ishiinaoto potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT horiiakira potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem AT unnomichiaki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem |
_version_ |
1725776757302231040 |